Competition

Dutch competition authority extends excessive pricing inquiry to consider possible supply restrictions on orphan ingredients

Francesca Miotto

Last week, the Dutch Authority for Consumers and Markets (ACM) announced that it is investigating whether the Italian pharmaceutical company Leadiant Biosciences restricted the supply of an important raw material for a patented orphan drug, by entering into exclusive agreements with an unnamed supplier. Such supply restrictions for raw materials could, according to the ACM, Read More

French Competition Authority delivers its opinion on consumer supply of medicines

Eveline Van Keymeulen

On 4 April 2019, the French Competition Authority delivered its opinion on the distribution of medicines to consumers, following several months of investigation and an extensive public consultation. According to the Authority, the consumer supply of medicines sector is particularly important to the French economy and is evolving rapidly and significantly. This evolution is due Read More

Dutch antitrust watchdog publishes additional notification requirements for healthcare mergers

Iradj Nazaryar

The Dutch Authority for Consumers and Markets (ACM) has published a new method of analysing product markets in merger investigations with respect to specialised medical care. In this context, the ACM requires merging hospitals and independent treatment centres to provide more detailed information in their merger notifications to the ACM. The starting point for the Read More

Coordination amongst member states on medicines’ prices supported by the European Commission

Nele De Backer

European Commissioner for Health and Food Safety, Vytenis Andriukaitis, said that the European Commission will support national competition authorities in their probes against excessive pricing practices in pharmaceutical markets. In addition, the European Commission will continue to monitor pharmaceutical markets itself, as part of its competition policy, and is ready to act against infringements of Read More

European Commission issues report on antitrust enforcement in the pharmaceutical sector

Dominc Long

A decade on from its inquiry into the pharmaceutical sector in 2009, on 28 January 2019 the European Commission (EC) issued a report providing an overview of antitrust law enforcement (antitrust and mergers) in the EU from 2009-2017 in the pharmaceutical sector. The report confirms that effective enforcement of EU antitrust rules in the sector Read More